Tune in for daily updates and reactions from attendees at the 2015 International Meeting for Autism Research in Salt Lake City, Utah.

Some children with autism lose their diagnosis over time, but still struggle with language, learning and anxiety, says Lisa Shulman.

Fixing the gene that’s faulty in Angelman syndrome ameliorates anxiety and motor deficits in a mouse model of the disorder, but only if done early in life.

With billions of dollars in hand, a novel initiative is funding projects that involve people with disorders and their caregivers from the outset.

Only one type of intervention for adults with autism has held up in rigorous scientific studies, according to the largest review of these treatments to date.

Researchers are using social media and an online ‘brain-training’ program to study people with rare chromosomal abnormalities linked to autism.

Peer review panels really can suss out good science, and clinical trials could get extremely personal.

Two new studies give a boost to arbaclofen, which failed to meet expectations in clinical trials for autism and fragile X syndrome.

Newt Gingrich wants to double spending on medical research, and Chinese researchers highlight the hazards of editing human genomes.

The National Institute of Mental Health is overhauling its funding strategy to emphasize the translation of advances in genomics and information technology into therapies.